Predictive probability of success using surrogate endpoints

DOI10.1002/SIM.8060MaRDI QIDQ6625585zbMATH OpenFDO

Authors Gaelle Saint-Hilary, Valentine Barboux, Matthieu Pannaux, Mauro Gasparini, Veronique Robert, Gianluca Mastrantonio

Publication date 28 October 2024

Published in Statistics in Medicine (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1002/SIM.8060

zbMATH Keywords

Bayesian analysisdecision-makingpredictionsprobability of successsurrogate endpoints

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites work

• Bayes and empirical Bayes methods for data analysis.
• Meta-analytic-predictive use of historical variance data for the design and analysis of clinical trials
• On meta-analytic assessment of surrogate outcomes
• Robust meta‐analytic‐predictive priors in clinical trials with historical control information
• Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
• The evaluation of surrogate endpoints.
• The validation of surrogate endpoints in meta-analyses of randomized experiments

Cited in

(5)

• DOD-SSR: an adaptive seamless phase II/III design with dose optimization decision and sample size re-estimation
• Incorporation of healthy volunteers data on receptor occupancy into a phase II proof-of-concept trial using a Bayesian dynamic borrowing design
• Group sequential testing of a treatment effect using a surrogate marker
• Dual-criterion approach incorporating historical information to seek accelerated approval with application in time-to-event group sequential trials
• Efficient testing using surrogate information

This page was built for publication: Predictive probability of success using surrogate endpoints

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6625585)